ANDA 75343, held by Teva Pharmaceuticals. Albuterol Sulfate.
As of Nov 21, 2026, ANDA 75343 (Albuterol Sulfate), held by Teva Pharmaceuticals, was first approved by FDA on Nov 9, 1999, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 9, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 0.083% BASE · solution;inhalation | Albuterol Sulfate | Discontinued |
| Aug 27, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Aug 27, 2001 | Supplement 2Labeling | Approved | None posted |
| Nov 9, 1999 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters